Invention Grant
- Patent Title: Methods for improving bioavailability of a renin inhibitor
- Patent Title (中): 提高肾素抑制剂生物利用度的方法
-
Application No.: US11572471Application Date: 2005-08-02
-
Publication No.: US07709532B2Publication Date: 2010-05-04
- Inventor: Gian P. Camenisch , Gerhard Gross , Isabel Ottinger , Daniel Wasmuth
- Applicant: Gian P. Camenisch , Gerhard Gross , Isabel Ottinger , Daniel Wasmuth
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Lisa M. Matovcik; Gregory D. Ferraro
- International Application: PCT/EP2005/008369 WO 20050802
- International Announcement: WO2006/013094 WO 20060209
- Main IPC: A61K31/165
- IPC: A61K31/165 ; A61P9/00
Abstract:
The present invention provides a method for improving the bioavailability of a renin inhibitor, preferably, of a δ-amino-γ-hydroxy-ω-aryl-alkanoic acid derivative, which method comprises co-administering to a mammal, especially a human, in need of such treatment, a combination of a renin inhibitor, or a pharmaceutically acceptable salt thereof, and an efflux protein inhibitor.
Public/Granted literature
- US20080108703A1 Methods for Improving Bioavailability of a Renin Inhibitor Public/Granted day:2008-05-08
Information query
